Intellia Therapeutics Inc. (38I)
Market Closed
17 Jul, 20:00
€
10. 20
-0.7
-6.422%
€
- Market Cap
- P/E Ratio
- Div Yield
300 Volume
-5.42 Eps
€ 10.9
Previous Close Want to track 38I and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
38I Earnings Reports FAQ
What is the earnings per share (EPS) for 38I?
The current EPS is -5.42.
What is the company's earnings growth rate?
Intellia Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Intellia Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Intellia Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 38I at this time, as Intellia Therapeutics Inc has no recent EPS data to calculate it.
